Johnson E E, Connor M
Pain Management Research Institute, Kolling Institute, University of Sydney, E25 Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Br J Pharmacol. 2007 Oct;152(4):415-6. doi: 10.1038/sj.bjp.0707384. Epub 2007 Jul 9.
Nocistatin is a peptide derived from the pronociceptin precursor, the source of nociceptin, the endogenous ligand for the nociceptin (NOP or ORL1). Despite nocistatin showing activity in a wide range of assays for nociception and other CNS activities, there is a dearth of information regarding the cellular actions of this peptide in the brain, and no receptor for nocistatin has been identified. In a study published in this issue of the British Journal of Pharmacology, Fantin and colleagues demonstrate that nocistatin inhibits 5-HT release from cortical synaptosomes in a concentration-dependent and Pertussis toxin-sensitive manner. The actions of nocistatin are independent of activity at NOP receptors. This study represents the first unambiguous demonstration of nocistatin agonist actions in brain and, taken together with previous work in the spinal cord, provides strong evidence that there is an as yet unidentified G protein-coupled receptor for nocistatin.
痛稳素是一种由痛敏肽前体衍生而来的肽,痛敏肽是痛稳素的来源,痛稳素是孤啡肽(NOP或ORL1)的内源性配体。尽管痛稳素在多种伤害感受和其他中枢神经系统活动的检测中表现出活性,但关于这种肽在大脑中的细胞作用的信息却很匮乏,而且尚未鉴定出痛稳素的受体。在本期《英国药理学期刊》上发表的一项研究中,方丹及其同事证明,痛稳素以浓度依赖性和百日咳毒素敏感的方式抑制皮质突触体释放5-羟色胺。痛稳素的作用独立于其对NOP受体的活性。这项研究首次明确证明了痛稳素在大脑中的激动剂作用,并且与之前在脊髓方面的研究一起,提供了强有力的证据,表明存在一种尚未鉴定的痛稳素G蛋白偶联受体。